183742-29-2

• 常用中文名：1-N-BOC-3-哌嗪羧酸乙酯
• 常用英文名：1-Tert-Butyl 3-Ethyl Piperazine-1,3-Dicarboxylate
• CAS号：183742-29-2
• 分子式：C₁₂H₂₂N₂O₄
• 分子量：258.31400
• 发布时间：2018-12-21 11:29:33
• 更新时间：2025-09-18 22:58:05

名称

• 中文名: 1-N-Boc-3-哌嗪羧酸乙酯
• 英文名: 1-O-tert-butyl 3-O-ethyl piperazine-1,3-dicarboxylate
• 英文别名: 1-(tert-butyloxycarbonyl)-3-ethoxycarbonyl-piperazine; 1-(tert-butyl) 3-ethyl piperazine-1,3-dicarboxylate; 1-tert-butoxycarbonyl-3-ethoxycarbonylpiperazine; 1-(1,1-dimethylethyl)-3-ethyl 1,3-piperazinedicarboxylate; piperazine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester; 1-tert-Butoxycarbonylpiperazine-3-carboxylic acid ethyl ester; 1,3-Piperazinedicarboxylic acid,1-(1,1-dimethylethyl) 3-ethyl ester; ethyl 4-(1,1-dimethylethoxycarbonyl)-2-piperazinecarboxylate

物化性质

• 密度: 1.128g/cm3
• 沸点: 384.421ºC at 760 mmHg
• 分子式: C₁₂H₂₂N₂O₄
• 分子量: 258.31400
• 闪点: 186.292ºC
• 精确质量: 258.15800
• PSA: 67.87000
• LogP: 1.02510
• 蒸汽压: 0mmHg at 25°C
• 折射率: 1.484
• 储存条件: 2-8°C

安全

• 海关编码: 2933599090

合成路线

89941-07-1 24424-99-5 ~94% 183742-29-2

文献：Pfizer Inc. Patent: US6297380 B1, 2001 ;

89941-07-1 218947-56-9 ~99% 183742-29-2

文献：Wyeth Holdings Corporation Patent: EP1144368 B1, 2004 ; Location in patent: Page 51 ;

336818-63-4 ~% 183742-29-2

文献：TANABE SEIYAKU CO., LTD. Patent: EP1307455 B1, 2005 ; Location in patent: Page/Page column 33 ;

39684-80-5 ~% 183742-29-2

文献：Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W. Organic Letters, 2014 , vol. 16, # 4 p. 1236 - 1239

24424-99-5 ~% 183742-29-2

文献：Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W. Organic Letters, 2014 , vol. 16, # 4 p. 1236 - 1239

77361-32-1 ~% 183742-29-2

文献：Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W. Organic Letters, 2014 , vol. 16, # 4 p. 1236 - 1239

上下游产品

上游产品  5
89941-07-1 24424-99-5 336818-63-4 39684-80-5
77361-32-1
下游产品  0

海关

海关编码	2933599090
中文概述	2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%